Who are Methoxyflurane, MEOF's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Sevoflurane+Nitrous oxide, Sevoflurane Inhalational Induction and Maintenance, Desflurane Inhalant Product, Methoxyflurane - Penthrox, Methoxyflurane (M), generic sevoflurane.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/methoxyflurane-meof.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-09 · How we verify

Methoxyflurane, MEOF — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Methoxyflurane, MEOF (Methoxyflurane, MEOF) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Volatile halogenated ether anesthetic. Area: Anesthesia, Acute Pain Management.

marketed Volatile halogenated ether anesthetic GABA receptors, NMDA receptors Anesthesia, Acute Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Methoxyflurane, MEOF (Methoxyflurane, MEOF) — Sunnybrook Health Sciences Centre. Methoxyflurane is a volatile halogenated ether anesthetic that depresses the central nervous system to produce anesthesia and analgesia.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Methoxyflurane, MEOF TARGET	Methoxyflurane, MEOF	Sunnybrook Health Sciences Centre	marketed	Volatile halogenated ether anesthetic	GABA receptors, NMDA receptors
Sevoflurane+Nitrous oxide	Sevoflurane+Nitrous oxide	Huazhong University of Science and Technology	marketed	General anesthetic (volatile anesthetic + inhalational anesthetic)	GABA receptors, NMDA receptors
Sevoflurane Inhalational Induction and Maintenance	Sevoflurane Inhalational Induction and Maintenance	Abbott	marketed	Volatile anesthetic agent	GABA receptors, NMDA receptors, potassium channels
Desflurane Inhalant Product	Desflurane Inhalant Product	Sichuan Provincial People's Hospital	marketed	Volatile inhalational anesthetic	GABA receptors, NMDA receptors, potassium channels
Methoxyflurane - Penthrox	Methoxyflurane - Penthrox	St. Paul's Hospital, Canada	phase 3	Volatile halogenated anesthetic	GABA receptors, NMDA receptors
Methoxyflurane (M)	Methoxyflurane (M)	Oslo University Hospital	marketed	Volatile halogenated ether anesthetic
generic sevoflurane	generic sevoflurane	Asan Medical Center	marketed	Volatile halogenated ether anesthetic	GABA-A receptor, NMDA receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Volatile halogenated ether anesthetic class)

Asan Medical Center · 1 drug in this class
Oslo University Hospital · 1 drug in this class
Sunnybrook Health Sciences Centre · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Methoxyflurane, MEOF — Competitive Intelligence Brief. https://druglandscape.com/ci/methoxyflurane-meof. Accessed 2026-06-09.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing